ClinicalTrials.Veeva
Menu

Find clinical trials for Eczema in Berlin, BE

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Atopic Dermatitis
Dermatitis
Pruritus
Food Hypersensitivity
Hidradenitis
Hidradenitis Suppurativa
Hypersensitivity

Eczema trials near Berlin, BE, DEU:

Effectiveness and Safety of Lebrikizumab Treatment in Adults and Adolescents With Moderate-to-Severe Atopic Dermatitis (ADhope)

The main purpose of this study is to evaluate the effectiveness of 24 weeks of lebrikizumab in improving disease severity, signs, and symptoms in adu...

Active, not recruiting
Eczema
Atopic Dermatitis
Biological: Lebrikizumab

Phase 3

Almirall
Almirall

Berlin, Germany and 32 other locations

The purpose of this study is to assess the safety, tolerability, drug levels, drug effects, and impact on disease severity of BMS-986326 in participa...

Active, not recruiting
Dermatitis, Atopic
Other: Placebo
Drug: BMS-986326

Phase 1

Bristol-Myers Squibb (BMS)
Bristol-Myers Squibb (BMS)

Berlin, BE, Germany and 13 other locations

B7451015 is a Phase 3 study to evaluate Abrocitinib with or without Topical Medications in patients aged 12 years and older who have moderate to seve...

Active, not recruiting
Dermatitis, Atopic
Drug: Abrocitinib 200 mg
Drug: Abrocitinib 100 mg

Phase 3

Pfizer
Pfizer

Berlin, Germany and 540 other locations

The main purpose of the study is to assess the long-term tolerability and effectiveness of lebrikizumab in adult and adolescent participants with mod...

Active, not recruiting
Atopic Dermatitis
Biological: Lebrikizumab

Phase 3

Almirall
Almirall

Berlin, Germany and 31 other locations

In this study, it will be investigated if symptoms of atopic dermatitis of children with high familial risk will be delayed beyond the 6th or even 12...

Enrolling
Atopic Dermatitis
Infant, Newborn
Drug: SanaCutan Basiscreme

Phase 3

InfectoPharm

Berlin, Germany and 9 other locations

The primary objective of this study is to describe the long-term safety and tolerability of rocatinlimab in participants with moderate-to-severe AD.

Active, not recruiting
Atopic Dermatitis
Other: Placebo
Drug: Rocatinlimab

Phase 3

Amgen
Amgen

Berlin, Germany and 555 other locations

This is an interventional, randomized, parallel group, treatment, Phase IIb, double blind, 4-arm study to assess the effect of pegylated-recombinant-...

Active, not recruiting
Moderate to Severe Atopic Dermatitis
Drug: Rezpegaldesleukin
Drug: Placebo

Phase 2

Nektar Therapeutics
Nektar Therapeutics

Berlin, Germany and 118 other locations

Long-Term Safety and Efficacy of Nemolizumab in Subjects with Moderate-to-Severe Atopic Dermatitis Description

Active, not recruiting
Moderate-to-Severe Atopic Dermatitis
Drug: Nemolizumab

Phase 3

Galderma
Galderma

Berlin, Germany and 342 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems